Protein Synthesis in Midthigh Muscles PET/CT

Sarcopenia Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01008839
• Other study ID #: Protein Synthesis
• Secondary ID: TLANG_Protiensyn
• Status: Completed
• Phase: N/A
• First received: November 5, 2009
• Last updated: May 13, 2011
• Start date: March 2010

Study information

• Verified date: May 2011
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to test a new imaging technique to help scientists study sarcopenia, the process by which muscle becomes weaker with age.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 25 Years to 90 Years

Eligibility

Inclusion Criteria:

• young healthy women aged 25-35 years and older healthy women above 70 years old.

Exclusion Criteria:

• no cardiac disease, not taking medication for high blood pressure Asthma HIV any other cardiac conditions

Study Design

N/A

Related Conditions & MeSH terms

• Sarcopenia

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Francisco